165 related articles for article (PubMed ID: 11322935)
1. Inhibition of T-cell invasion across cultured fibroblast monolayers by phenothiazine-related calmodulin inhibitors: impairment of lymphocyte motility by trifluoperazine and chlorpromazine, and alteration of the monolayer by pimozide.
Grabski R; Dewit J; De Braekeleer J; Malicka-Blaskiewicz M; De Baetselier P; Verschueren H
Biochem Pharmacol; 2001 May; 61(10):1313-7. PubMed ID: 11322935
[TBL] [Abstract][Full Text] [Related]
2. Effects of calmodulin antagonists on immune mouse lymphocytes.
Wolberg G; Zimmerman TP
Mol Pharmacol; 1984 Sep; 26(2):286-92. PubMed ID: 6482875
[TBL] [Abstract][Full Text] [Related]
3. Trifluoperazine inhibits spreading and migration of cells in culture.
Connor CG; Brady RC; Brownstein BL
J Cell Physiol; 1981 Sep; 108(3):299-307. PubMed ID: 7287823
[TBL] [Abstract][Full Text] [Related]
4. The role of calmodulin in the responses to adrenocorticotropin of plasma membranes from adrenal cells.
Papadopoulos V; Widmaier EP; Hall PF
Endocrinology; 1990 May; 126(5):2465-73. PubMed ID: 2158426
[TBL] [Abstract][Full Text] [Related]
5. Induction of early growth response-1 gene expression by calmodulin antagonist trifluoperazine through the activation of Elk-1 in human fibrosarcoma HT1080 cells.
Shin SY; Kim SY; Kim JH; Min DS; Ko J; Kang UG; Kim YS; Kwon TK; Han MY; Kim YH; Lee YH
J Biol Chem; 2001 Mar; 276(11):7797-805. PubMed ID: 11121417
[TBL] [Abstract][Full Text] [Related]
6. Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3R.
Kang S; Hong J; Lee JM; Moon HE; Jeon B; Choi J; Yoon NA; Paek SH; Roh EJ; Lee CJ; Kang SS
Mol Cancer Ther; 2017 Jan; 16(1):217-227. PubMed ID: 28062709
[TBL] [Abstract][Full Text] [Related]
7. The voltage- and time-dependent blocking effect of trifluoperazine on T lymphocyte Kv1.3 channels.
Teisseyre A; Michalak K
Biochem Pharmacol; 2003 Feb; 65(4):551-61. PubMed ID: 12566082
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of phenothiazines in inhibiting lymphocyte motility as determined by a novel flow cytometric assay.
Matthews N; Franklin RJ; Kendrick DA
Biochem Pharmacol; 1995 Sep; 50(7):1053-61. PubMed ID: 7575661
[TBL] [Abstract][Full Text] [Related]
9. Effects of trifluoperazine, a calmodulin antagonist, on rabbit T- and B-cell responses to mitogens and antigen.
Stavitsky AB; Dasch JR; Astrachan L
Cell Immunol; 1984 Sep; 87(2):411-23. PubMed ID: 6331894
[TBL] [Abstract][Full Text] [Related]
10. Characterization of inhibition by haloperidol and chlorpromazine of a voltage-activated K+ current in rat phaeochromocytoma cells.
Nakazawa K; Ito K; Koizumi S; Ohno Y; Inoue K
Br J Pharmacol; 1995 Nov; 116(6):2603-10. PubMed ID: 8590977
[TBL] [Abstract][Full Text] [Related]
11. Calcium transport by sarcoplasmic reticulum of vascular smooth muscle: II. Effects of calmodulin and calmodulin inhibitors.
Stout MA; Silver PJ
J Cell Physiol; 1992 Oct; 153(1):169-75. PubMed ID: 1522130
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of secretion of rat calcitonin by calmodulin inhibitors.
Cooper CW; Borosky SA
Calcif Tissue Int; 1986 Feb; 38(2):103-8. PubMed ID: 3082492
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulin.
Lee GL; Hait WN
Life Sci; 1985 Jan; 36(4):347-54. PubMed ID: 2981390
[TBL] [Abstract][Full Text] [Related]
14. Lack of calmodulin antagonism of melatonin in T-lymphocyte activation.
Wölfler A; Schauenstein K; Liebmann PM
Life Sci; 1998; 63(10):835-42. PubMed ID: 9734703
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of trifluoperazine and chlorpromazine, calmodulin inhibitor, on autoregulation of renal blood flow.
Ogawa N; Yokota S; Ono H
Jpn J Pharmacol; 1987 Mar; 43(3):331-4. PubMed ID: 2438442
[TBL] [Abstract][Full Text] [Related]
16. [Effect of calmodulin blockers on membrane potential, potassium permeability and lymphocyte mitogenesis].
Gukovskaia AS; Zinchenko VP; Astashkin EI
Biokhimiia; 1985 May; 50(5):786-94. PubMed ID: 3924125
[TBL] [Abstract][Full Text] [Related]
17. Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists.
Lazo JS; Hait WN; Kennedy KA; Braun ID; Meandzija B
Mol Pharmacol; 1985 Mar; 27(3):387-93. PubMed ID: 2579318
[TBL] [Abstract][Full Text] [Related]
18. Acute inhibition of corticosteroidogenesis by inhibitors of calmodulin action.
Carsia RV; Moyle WR; Wolff DJ; Malamed S
Endocrinology; 1982 Nov; 111(5):1456-61. PubMed ID: 6290182
[TBL] [Abstract][Full Text] [Related]
19. The effect of calmodulin inhibitors of the adenylate cyclase system.
Okruhlicová L; Slezák J
Physiol Bohemoslov; 1990; 39(2):151-5. PubMed ID: 2168569
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of calmodulin binding to purified human lymphocyte plasma membranes.
Lee TP; Venuti J; Macara I; Kawauchi R; Davis PJ; Mookerjee BK
J Immunol; 1987 Jul; 139(1):42-8. PubMed ID: 3584987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]